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Background: Ten neurodegenerative disorders char-
acterized by spinocerebellar ataxia (SCA) are known to
be caused by trinucleotide repeat (TNR) expansions. How-
ever, in some instances the molecular diagnosis is con-
sidered indeterminate because of the overlap between nor-
mal and affected allele ranges. In addition, the mechanism
that generates expanded alleles is not completely under-
stood.
Objective: To examine the clinical and molecular char-
acteristics of a large group of Portuguese and Brazilian
families with ataxia to improve knowledge of the mo-
lecular diagnosis of SCA.
PatientsandMethods:We have (1) assessed repeat sizes
at all known TNR loci implicated in SCA; (2) determined
frequency distributions of normal alleles and expansions;
and (3) looked at genotype-phenotype correlations in 202
unrelated Portuguese and Brazilian patients with SCA. Mo-
lecular analysis of TNR expansions was performed using
polymerase chain reaction amplification.
Results: Patients from 110 unrelated families with SCA
showed TNR expansions at 1 of the loci studied. Domi-
nantly transmitted cases had (CAG)n expansions at the
Machado-Joseph disease gene (MJD1) (63%), at SCA2 (3%),
the gene for dentatorubropallidoluysian atrophy (DRPLA)
(2%), SCA6 (1%), or SCA7 (1%) loci, or (CTG)n expan-
sions at the SCA8 (2%) gene, whereas (GAA)n expan-
sions in the Freidreich ataxia gene (FRDA) were found in
64% of families with recessive ataxia. Isolated patients also
had TNR expansions at the MJD1 (6%), SCA8 (6%), or
FRDA (8%) genes; in addition, an expanded allele at the
TATA-binding protein gene (TBP), with 43 CAGs, was pres-
ent in a patient with ataxia and mental deterioration. As-
sociations between frequencies of SCA2 and SCA6 and a
frequency of large normal alleles were found in Portu-
guese and Brazilian individuals, respectively. Interest-
ingly, no association between the frequencies of DRPLA
and large normal alleles was found in the Portuguese group.
Conclusions: Our results show that (1) a significant num-
ber of isolated cases of ataxia are due to TNR expansions;
(2) expanded DRPLA alleles in Portuguese families may have
evolved from an ancestral haplotype; and (3) small (CAG)n
expansions at the TBP gene may cause SCA17.
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T HE SPINOCEREBELLAR atax-ias (SCAs) are neurodegen-erative disorders that areclinically and geneticallyheterogeneous. Ten geneti-
cally different SCAs are known to be caused
by trinucleotide repeat (TNR) expansions.
In the dominant SCAs, the mutant pro-
teins show an expanded polyglutamine tract
in SCA1, SCA2, Machado-Joseph disease
(MJD), SCA6, SCA7, and dentatorubropal-
lidoluysian atrophy (DRPLA),1-9 whereas
SCA8 and SCA12 are caused by untrans-
lated (CTG)n and (CAG)n expansions, re-
spectively.10,11 In Friedreich ataxia (FRDA),
the mutant protein is deficient in homozy-
gotes for a (GAA)n expansion in intron 1 of
the FRDA gene.12 Recently, an expanded
CAG repeat tract has been found at the
TATA-binding protein gene (TBP) in an iso-
lated patient with symptoms of ataxia and
intellectual deterioration.13 TBP repeat ex-
pansions have since been described in 4
Japanese families affected by a new type of
ataxia with dementia named SCA17.14 Mat-
suura et al15 found a large expansion of pen-
tanucleotide (ATTCT)n in intron 9 of the
SCA10 gene in patients with spinocerebel-
lar ataxia type 10, thus being the first to
show the existence of a new class of dy-
namic mutations.
Function of the genes involved is
known only for SCA6, SCA12, and SCA17.
SCA6 is due to a small CAG expansion
(21-33 CAGs) in the coding region of a volt-
age-gated calcium channel -subunit gene
(CACNA1A).9 SCA12 is caused by a CAG
expansion in the 5-untranslated region of
a brain-specific regulatory subunit of the
protein phosphatase PP2A gene.11 The re-
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cently described SCA17 is caused by a (CAG)n expansion
in the coding region of the transcription factor TBP gene.13
Associations between prevalence of dominantly in-
herited SCAs and frequency of large normal (CAG)n al-
leles have been found in Japanese and European popu-
lations, indicating that these may contribute to the
generation of expanded alleles in the SCAs.16
In an attempt to improve our understanding of TNR
expansions leading to SCA, we have (1) assessed repeat
size at the SCA1, SCA2, MJD1, SCA6, SCA7, SCA8, SCA12,
SCA17/TBP, DRPLA, and FRDA loci in a large group of
Portuguese and Brazilian patients with ataxia; (2) exam-
ined TNR distributions of normal alleles at these loci; (3)
determined the frequency of TNR expansions; (4) com-
pared frequencies of large normal alleles with relative fre-
quencies of SCA at each loci; and (5) looked for genotype-
phenotype correlations.
RESULTS
TNR DISTRIBUTIONS IN NORMAL ALLELES
The frequency distributions of normal alleles in the domi-
nant SCAs caused by translated TNR expansions in the Bra-
zilian group were not significantly different from those in
the Portuguese group (P>.05 using the Mann-Whitney U
test and Kolmogorov-Smirnov 2-sample test) (Figure 1).
In the case of the SCA2 locus, the normal (CAG)n alleles
ranged in size from 17 to 31 repeats in the Portuguese group
and from 19 to 24 repeats in the Brazilian group; the al-
lele with 22 repeats was the most frequent in both groups.
No significant differences were found between the 2 groups
at the most recently identified SCA8, SCA12, and SCA17/
TBP ataxia loci (Figure 1). Interestingly, no SCA8 alleles
smaller than 18 repeats and larger than 35 repeats in the
Portuguese patients, or larger than 30 repeats in the Bra-
zilian patients, were observed. A third class of extremely
large normal alleles at the SCA8 locus, varying in size from
40 to 91 CTG repeats,23 was not found in either group;
this might be due to the small sample size. At the SCA12
locus, small normal alleles were closely distributed around
an allele with 10 CAGs, which represented more than 65%
of all normal alleles in each group; the other class of nor-
mal alleles comprised CAG repeat sizes of 12 to 18 units.
A large normal SCA12 allele containing 28 CAG repeats
was also observed in the Portuguese group. The recently
described SCA17/TBP ataxia locus presented a distribu-
tion of normal allele sizes varying from 29 to 40 CAGs in
SUBJECTS, MATERIALS,
AND METHODS
SUBJECTS
Individuals with SCAs who were referred to UnIGENe, In-
stituto de Biologia Molecular e Celular (Porto, Portugal)
between 1997 and 2000 were included on a consecutive
basis. These individuals were referred to this laboratory for
the molecular diagnosis of SCAs. Dominant inheritance was
assumed based on the presence of at least 1 affected family
member in 2 or more successive generations. Recessive trans-
mission was presumed when the patient had a history of
consanguinity or siblings affected without (aged) affected
parents. An isolated occurrence was assumed in the ab-
sence of a family history. We studied 202 unrelated fami-
lies: 145 lived in Portugal, and 57 in Brazil. Dominant in-
heritance was apparent in 106 families, whereas recessive
transmission was suspected in 33 Portuguese families; 63
individuals had isolated cases of SCA.
METHODS
Peripheral blood was collected from patients and their rela-
tives after written informed consent was obtained. Ge-
nomic DNA was isolated from peripheral blood leuko-
cytes using standard techniques.17
Molecular analysis of the CAG and CTG repeat loci
were performed by polymerase chain reaction (PCR) am-
plification using the published primer sequences;1,4,6,8-11,18
the PCR was carried out with 1µM of each primer, 200µM
of deoxynucleotides, 1.0mM of magnesium chloride, 10mM
of Tris (pH 9.0), 50mM of potassium chloride, 1 U of Taq
polymerase, and 2% formamide, in a final volume of 25 µL.
Samples were processed as previously described.6,9,19,20
Polymerase chain reaction products were analyzed on 6%
polyacrylamide gels. Allele sizes were determined by com-
paring migration relative to an M13 sequencing ladder.
DNA sequencing was performed to accurately assess repeat
size and the presence of interruptions. Sequencing reac-
tions were performed using a ThermoSequenase DNA se-
quencing kit (USB, Cleveland, Ohio) with 5 µL of amplified
DNA. Both the CTA and CTG repeats on the SCA8 gene are
polymorphic, and PCR assay determines the combined size
of the 2 repeats.
The analysis of the intronic (GAA)n on the FRDA gene
was performed by PCR using primers 2500F12 and
104FGAA21 for expanded alleles, and primers GAA-R and
GAA-F for normal alleles, following the conditions de-
scribed.22 Expanded allele sizes were analyzed by compar-
ing migration relative to molecular weight standards. Nor-
mal sizes were assessed by analysis of fluorescent-labeled
PCR products in an automated DNA sequencer (model 4200;
Li-COR, Lincoln, Neb) using 5.5% Long Ranger gels (FMC
Bioproducts, Rockland, Me).
STATISTICAL ANALYSES
Possible differences between Portuguese and Brazilian
groups in normal repeat frequency distributions were as-
sessed using 2 nonparametric tests: the Kolmogorov-
Smirnov 2-sample test and the Mann-Whitney U test. Al-
lele frequencies at each locus were estimated by the gene
count method, and heterozygosity (H) was calculated as
H = 1 −
n
i = 1
Xi
2,
where Xi is the estimated frequency of the ith allele at the lo-
cus. Statistical analyses of differences in estimates of hetero-
zygosity between Portuguese and Brazilian individuals, as
well as differences in the frequency of large normal alleles
for each locus, were performed with the Fisher exact test.
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both groups, with distributions peaking at the allele with
38 CAG units. At the FRDA gene, normal alleles can be
subdivided into 2 classes depending on their GAA repeat
length: short normal alleles, with 5 to 10 GAA triplets,
and long normal alleles, with 12 to 60 GAA triplets.24 At
this locus, long normal alleles represented 18% and 22%
of Portuguese and Brazilian individuals, respectively
(Figure 2A). Although the Brazilian group had a slightly
larger proportion of long normal alleles, this difference
was not significant.
The most polymorphic loci were DRPLA, MJD1,
SCA1, SCA8, SCA17/TBP, and SCA6, whereas SCA2, SCA7,
and SCA12 were the least polymorphic ones (Table 1).
FREQUENCY OF TNR EXPANSIONS
Analysis of loci involved in the SCAs showed that 110
unrelated patients (55%) had ataxia due to a TNR ex-
pansion. Analysis of loci with translated (CAG)n tracts
showed that 78 unrelated patients with ataxia had 1 al-
lele in the expanded range. Expansions at the MJD1 lo-
cus were found in 114 individuals, 102 affected and 12
asymptomatic, from 67 families that had ataxia with domi-
nant inheritance (63%), as well as in 4 isolated cases (6%).
Six individuals (5 affected) from 3 families with domi-
nant ataxia (3%) had an expanded allele at the SCA2 gene.
An expanded allele at the DRPLA locus was found in 5
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Figure 1. Distribution of triplet repeats in normal alleles at SCA1, SCA2, MJD1, SCA6, SCA7, DRPLA, SCA8, SCA12, and SCA17/TBP loci in studied individuals
of Portuguese (black bars) and Brazilian (hatched bars) origin. Vertical axes represent allele frequency, and horizontal axes represent number of repeat units.
SCA indicates spinocerebellar ataxia; MJD, Machado-Joseph disease; DRPLA, dentatorubropallidoluysian atrophy; and TBP, TATA-binding protein.
SCA6 and SCA12 refer to the loci for the respective diseases, not to the genes themselves.
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patients and 1 possibly affected individual, from 2 kin-
dreds with dominant ataxia (2%). One patient from a
family that had ataxia with dominant inheritance (1%)
had an expanded allele at the SCA6 locus. Three pa-
tients from 1 kindred with dominant ataxia (1%) had 1
expanded allele at the SCA7 gene. Analysis of the un-
translated (CTG)n at the SCA8 gene showed that 4 pa-
tients from 2 unrelated families with dominant ataxia
(2%), as well as 4 isolated cases (6%), exhibited 1 ex-
panded allele. Expansions of the intronic (GAA)n at the
FRDA gene (Figure 2B) were found in both alleles in 31
patients from 21 families with recessively inherited
ataxia (64%) and in 5 isolated cases (8%). Table 2
shows the frequency of TNR expansions for each SCA
by geographic origin.
FREQUENCY OF LARGE NORMAL ALLELES
Evidence from several populations has suggested that the
disease prevalence of many of these SCAs may be asso-
ciated with the presence of large normal alleles at the re-
spective loci.16 To study the frequency of TNR expan-
sions in our 2 groups relative to the frequency of normal
alleles of larger size at the various loci, we used the cri-
teria of Takano et al16 (Table 3). Large normal alleles
at the SCA1 (34 repeats) and SCA6 (13 repeats) loci
were significantly more frequent in Brazilian individu-
als than in the Portuguese individuals. Normal alleles in
the upper tail of the SCA2 distribution (22 repeats) ap-
peared to be overrepresented in the Portuguese group,
but the P value obtained was of borderline statistical
significance.
GENETIC AND CLINICAL FEATURES
OF PATIENTS
The clinical phenotypes were very heterogeneous. All of
our affected individuals showed clinical symptoms of cer-
ebellar ataxia, with or without other associated features.
Epilepsy was present in patients with DRPLA from 1 fam-
ily, only cognitive impairment was observed in some pa-
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Figure 2. A, Distribution of GAA repeats in normal allele classes at the Friedreich ataxia (FRDA) locus by geographic origin of studied individuals. B, Distribution of
GAA repeats in expanded alleles at the FRDA locus in 58 chromosomes from Portuguese patients.
Table 1. Heterozygosity Values for Dominant Ataxia Loci
by Geographic Origin*
Locus
Portuguese Group Brazilian Group
n Heterozygosity n Heterozygosity
SCA1 82 0.77 ± 0.05 23 0.78 ± 0.09
SCA2 91 0.31 ± 0.05 54 0.15 ± 0.05
MJD1 105 0.78 ± 0.04 26 0.73 ± 0.09
SCA6 95 0.60 ± 0.05 60 0.68 ± 0.06
SCA7 95 0.30 ± 0.05 19 0.37 ± 0.11
DRPLA 96 0.81 ± 0.04 65 0.82 ± 0.05
SCA8 92 0.76 ± 0.05 22 0.77 ± 0.09
SCA12 95 0.48 ± 0.05 19 0.53 ± 0.11
TBP 95 0.72 ± 0.05 22 0.64 ± 0.10
*Data are presented as mean ± SD. SCA indicates spinocerebellar ataxia;
MJD, Machado-Joseph disease; DRPLA, dentatorubropallidoluysian atrophy;
and TBP, TATA-binding protein. SCA6 and SCA12 refer to the loci for the
respective diseases, not to the genes themselves.
Table 2. Frequency of SCA TNR Expansions by Mode
of Inheritance and Geographic Origin*
TNR
Expansions
AD
Portuguese/
Brazilian
Families, %
AR
Portuguese/
Brazilian
Families, %
Isolated Cases
in Portuguese/
Brazilian
Individuals, %
Translated (CAG)n
SCA2 5/0 . . . . . .
MJD/SCA3 49/85 . . . 4/13
SCA6 0/2 . . . . . .
SCA7 0/2 . . . . . .
DRPLA 3/0 . . . . . .
Total 57/89 . . . 4/13
Untranslated (CTG)n
SCA8 3/0 . . . 6/6
Intronic (GAA)n
FRDA . . . 64/0 9/6
*SCA indicates spinocerebellar ataxia; TNR, trinucleotide repeat;
AD, autosomal dominant; AR, autosomal recessive; MJD, Machado-Joseph
disease; DRPLA, dentatorubropallidoluysian atrophy; FRDA, Friedreich ataxia;
and ellipses, not available. No expansions were found at either the SCA1 or
SCA12 locus in either population.
(REPRINTED) ARCH NEUROL / VOL 59, APR 2002 WWW.ARCHNEUROL.COM
626
©2002 American Medical Association. All rights reserved.
 at CENTRO HOSP DE COIMBRA, on February 20, 2009 www.archneurol.comDownloaded from 
tients with DRPLA and SCA8, and visual impairment was
seen in affected individuals with SCA7. Two of the 3 fami-
lies with SCA2 had been thought to have MJD. The fami-
lies with SCA6, SCA7, and SCA8 and 1 of the 2 kindreds
with DRPLA did not have a previous clinical diagnosis
of these disorders. Altogether, 13 patients with no fam-
ily history tested positive for a TNR expansion: 4 iso-
lated patients had a mutation for MJD (2 of them having
a clinical diagnosis of possible MJD), 3 of the 5 isolated
patients with FRDA expansions had a clinical diagnosis
of the disease, and the (CTG)n expansion at the SCA8 gene
was present in 4 isolated cases. Table 4 shows the mean
age at onset and expanded allele size ranges for patients
with TNR expansions.
SCA2 ALLELE WITH 32 CAG REPEATS
The analysis of the SCA2 gene in our patients disclosed
an allele with 32 CAGs in a 48-year-old isolated patient
who had been clinically diagnosed as having atypical
FRDA. Her age at onset of gait ataxia was 2 years; dur-
ing the following years, she developed a spinocerebellar
syndrome. The disease progressed rapidly as time passed,
with evidence of neuropathy and a mild cognitive im-
pairment; by age 30 years, she was nonambulatory. We
first tested the FRDA gene and identified 2 normal alle-
les; thus, we have proceeded with the analysis of other
known SCA mutations and detected an allele with 32 re-
peats at the SCA2 gene. Sequence analysis of this allele
showed an interrupted CAA repeat configuration: there-
fore, this is probably not a pathogenic allele. Moreover,
a recently performed muscle biopsy showed ragged-red
and cytochrome oxidase–negative fibers as well as re-
duced activity of the mitochondrial respiratory chain on
polarography.
SMALL EXPANDED ALLELE
AT THE SCA17/TBP LOCUS
Besides the mutations described previously, the analy-
sis of the CAG repeat at the TBP gene showed an ex-
panded allele with 43 units in a 64-year-old patient with
ataxia. Sequence analysis of this allele showed an inter-
rupted repeat configuration of (CAG)3(CAA)3(CAG)9
CAACAGCAA(CAG)23CAACAG, encoding 43 gluta-
mines. This patient began experiencing symptoms of gait
ataxia at age 52 years. During the last 5 years, he exhib-
ited progressive mental deterioration and dementia. The
family history indicated that his deceased mother pre-
sumably had the same disease. There are no other pa-
tients in this family. The normal allele range previously
described for TBP was 25 to 42 CAG repeats.13,25-27
COMMENT
DOMINANT ATAXIA AND FRDA
The analysis of TNR sizes at the loci implicated in SCA
in a large group of Portuguese and Brazilian patients al-
lowed the identification of an expansion in more than
half of them, including a significant number without a
family history. This study showed that DRPLA disease,
frequent in Asian populations28 but rare in European in-
dividuals,16 was present in the Portuguese families. On
the other hand, no expanded alleles were seen at the
SCA12 locus, confirming previous impressions that they
are very rare.11 (GAA)n expansions at the FRDA gene were
also frequent among our recessive Portuguese families
with ataxia (64%). The genetic basis of approximately 40%
of families with ataxia remains unknown.
In most cases of SCAs, phenotypic features are
helpful indicators of the underlying genotype. Demen-
tia and seizures associated with symptoms of cerebellar
ataxia are characteristic features of DRPLA29; however,
in 1 of our families with the DRPLA mutation, the only
patient available had symptoms of cerebellar ataxia
alone.
Table 3. Frequencies of Large Normal Alleles
at the Dominantly Inherited Ataxia Loci
in Portuguese and Brazilian Groups*
Locus Repeat Size Portuguese Group Brazilian Group
SCA1 33 0.11 0.15
34 0.02 0.15†
SCA2 22 0.13 0.06‡
23 0.04 0.01
MJD1 27 0.07 0.07
28 0.02 0.03
SCA6 13 0.02 0.10†
SCA7 14 0.02 0.02
DRPLA 16 0.07 0.05
17 0.06 0.04
SCA8 27 0.11 0.07
28 0.07 0.02
SCA12 15 0.03 0.05
TBP 38 0.05 0.07
39 0.01 0.02
*SCA indicates spinocerebellar ataxia; MJD, Machado-Joseph disease;
SCA6 and SCA12 refer to the loci for the respective diseases, not to the
genes themselves. DRPLA, dentatorubropallidoluysian atrophy; and TBP,
TATA-binding protein. SCA6 and SCA12 refer to the loci for the respective
diseases, not to the genes themselves.
†P = .003.
‡P = .05.
Table 4. Repeat Size and Age at Onset of Patients
With Expanded TNRs*
Expanded
TNR
No. of
Patients
Age at Onset,
Mean (SD), y
Expanded
Allele
Size Range
TNR Size in
Expanded
Alleles,
Mean (SD)
SCA2 6 34 (7) 39-46 41 (3)
MJD1 101 34 (13) 65-85 75 (3)
SCA6 1 34 25 25
SCA7 3 32 (14) 43-55 47 (7)
DRPLA 5 37 (11) 58-61 60 (1)
SCA8 7 21 (10) 100-152 119 (20)
TBP 1 52 43 43
FRDA 31 11 (4) 390-1100 858 (167)
*TNR indicates trinucleotide repeat; SCA, spinocerebellar ataxia;
MJD, Machado-Joseph disease; DRPLA, dentatorubropallidoluysian atrophy;
TBP, TATA-binding protein; and FRDA, Freidreich ataxia. SCA6 refers to the
locus for the disease, not to the gene.
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ISOLATED CASES OF TNR EXPANSIONS
We identified the molecular basis in 13 patients with ataxia
who had no family history. Eight (13%) did not have a
clinical diagnosis of a specific SCA type. A recent study
has also shown that 19% of cases of apparently idio-
pathic ataxia were due to TNR expansions.30 We pro-
pose that all isolated individuals with ataxia of un-
known cause should be investigated for TNR expansions
at known SCA loci.
SMALL CAG EXPANSION AT
THE SCA17/TBP GENE
The normal CAG size range described for the TBP gene
(in 2525 chromosomes belonging to individuals of Eu-
ropean, Asian, African American, and Hispanic origin)
was 25 to 42 repeat units.13,25-27 Previous findings have
implicated a de novo expansion of 63 CAG repeats at the
TBP gene in a 14-year-old Japanese patient, confined to
a wheelchair at age 13 years with symptoms of ataxia and
intellectual deterioration.13 Expansions in the SCA17/
TBP gene have also been found in 4 Japanese families with
ataxia and dementia in which expanded alleles were 47
to 55 CAG units.14 We found a TBP allele with 43 CAG
units in a 64-year-old affected individual with mild ataxia
and dementia; the late onset of disease as well as the mild
clinical symptoms seem to correlate with the small size
of the expanded allele (compared with the early onset
observed in the patient with 63 glutamines).
LARGE INDETERMINATE ALLELES
AT THE SCA2 GENE
Genetic diagnosis and counseling may sometimes be dif-
ficult with these diseases caused by TNR expansions. In
SCA1, for instance, there is no gap between normal and
pathological alleles, whereas SCA2 alleles with 32 and 33
CAGs have been considered of indeterminate signifi-
cance. Normal SCA1 and SCA2 CAG repeats are inter-
rupted by CAT or CAA triplets, respectively, whereas patho-
genic expansions are pure, uninterrupted CAG repeats.6,29
Uninterrupted alleles with 32 CAGs31 and 33 repeat units32
have been found in young, at-risk subjects in families with
SCA2, both resulting from the contraction of alleles with
40 repeats. Recently, another SCA2 allele with 33 unin-
terrupted CAG units was found in a patient with a mild
balance problem; this patient had an onset at age 60 years.33
We found an SCA2 allele with 32 CAGs interrupted by a
CAA triplet in a patient with a childhood onset of severe
ataxia. The severe phenotype, the altered function of the
mitochondrial respiratory chain, and the presence of a CAA
interruption suggest that this SCA2 allele is not the cause
of the disease in this case. As in SCA1, in SCA2 there is
no gap between normal and pathological alleles.
ASSOCIATIONS BETWEEN PREVALENCE
OF SCAs AND LARGE NORMAL ALLELES
Our present findings indicate that for both SCA2 and SCA6
TNRs, large normal alleles may contribute to the gen-
eration of expanded alleles and thus to the relative fre-
quency of these SCAs in the 2 groups. For the remain-
ing loci, the frequency of normal alleles was similar in
the 2 groups. Of interest is the fact that no association
between the frequency of DRPLA and that of large nor-
mal alleles was found in the Portuguese group. This may
be owing to the effect of a specific haplotype associated
with large normal alleles, shared with patients who have
DRPLA, that is prone to further expansion into the dis-
ease range. In a group of Japanese individuals, all ex-
panded and intermediate DRPLA alleles shared a unique
haplotype that is frequent in Asian populations and is usu-
ally associated with large normal alleles.28 The same hap-
lotype has also been found in European patients, al-
though it rarely occurs in normal chromosomes in this
population. This suggests that DRPLA expanded alleles
in Japanese28 and Portuguese patients may have evolved
from a common founder chromosome. Haplotype analy-
ses in our families with DRPLA are now being carried out
to test this hypothesis.
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